US Patent and Trademark Office Director Kathi Vidal granted
The Patent Trial and Appeal Board erred by relying on another tribunal decision that the director had vacated when it denied the medical device company’s petition to invalidate a patent covering technology to treat sleep disorders, the Nov. 16 decision said. Vidal vacated the denial and allowed each party to supplement their briefing about time-to-trial statistics of the judge in the district court litigation.
The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.